Multivariate epidemiologic analysis of type 2 diabetes mellitus risks in the Lebanese population

Diabetology and Metabolic Syndrome

Volumn 6, Issue 1, 2014, Pages

  Ghassibe Sabbagh, Michella ^a   Deeb, Mary ^a   Salloum, Angelique K ^a   Mouzaya, Francis ^a   Haber, Marc ^a   Al Sarraj, Yasser ^b   Chami, Youssef ^a   Akle, Yasmine ^c   Hirbli, Kamal ^a   Nemr, Rita ^a   Ahdab, Rechdi ^a   Platt, Daniel E ^d   Abchee, Antoine B ^e   El Shanti, Hatem ^b   Zalloua, Pierre A ^a,f  

^a LEBANESE AMERICAN UNIVERSITY   (Lebanon)

^b Shafallah Medical Genetics Center   (Qatar)

^c Centre Hospitalier du Nord CHN   (Lebanon)

^d IBM T J WATSON RESEARCH CENTER   (United States)

^e AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Coronary artery disease; Hyperlipidemia; Lebanon; Prediabetes; Risk factors; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; EXERCISE; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; LEBANESE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; QUESTIONNAIRE; REPRODUCTIVE HEALTH; RISK ASSESSMENT; SELF REPORT; TRIACYLGLYCEROL BLOOD LEVEL; WOMEN'S HEALTH;

EID: 84906927524     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-6-89     Document Type: Article

References (28)

1. International Diabetes Federation, Diabetes Atlas 5th edition Brussels, Belgium 2012 http://www.idf.org/diabetesatlas
2. Genome-wide association study in a Lebanese cohort confirms PHACTR1 as a major determinant of coronary artery stenosis. Hager J, Kamatani Y, Cazier JB, Youhanna S, Ghassibe-Sabbagh M, Platt DE, Abchee AB, Romanos J, Khazen G, Othman R, Badro DA, Haber M, Salloum AK, Douaihy B, Shasha N, Kabbani S, Sbeite H, Chammas E, el Bayeh H, Rousseau F, Zelenika D, Gut I, Lathrop M, Farrall M, Gauguier D, Zalloua PA, PLoS One 2012 7 38663 10.1371/journal.pone.0038663 22745674
3. Diagnosis and classification of diabetes mellitus. American Diabetes Association, Diabetes Care 2010 33 1 62 69 20042775
4. R Development Core Team, R: a language and environment for statistical computing Vienna, Austria: R Foundation for Statistical Computing ISBN 3-900051-07-0 2013
5. National Diabetes Fact Sheet, National estimates and general information on diabetes and prediabetes in the United States Atlanta, GA: US Department of Health and Human Services, CDC 2011 http://www.cdc.gov/diabetes/pubs/factsheet11.htm
6. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, N Engl J Med 2002 346 393 403 11832527
7. Deriving ethnic-specific BMI cutoff points for assessing diabetes risk. Chiu M, Austin PC, Manuel DG, Shah BR, Tu JV, Diabetes Care 2011 34 1741 1748 10.2337/dc10-2300 21680722
8. Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ma RC, Chan JC, Ann N Y Acad Sci 2013 1281 64 91 10.1111/nyas.12098 23551121
9. Overweight and obesity in the Arabian Peninsula: an overview. al-Mahroos F, al-Roomi K, J R Soc Promot Health 1999 119 251 253 10.1177/146642409911900410 10673848
10. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Bellamy L, Casas JP, Hingorani AD, Williams D, Lancet 2009 373 1773 1779 10.1016/S0140-6736(09)60731-5 19465232
11. Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? Catalano PM, Hauguel-De Mouzon S, Am J Obstet Gynecol 2011 204 479 487 10.1016/j.ajog.2010.11.039 21288502
12. Abnormal glucose screening tests in pregnancy: a risk factor for fetal macrosomia. Leikin EL, Jenkins JH, Pomerantz GA, Klein L, Obstet Gynecol 1987 69 570 573 3822298
13. Hyperglycemia and adverse pregnancy outcomes. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA, N Engl J Med 2008 358 1991 2002 18463375
14. Etiology, detection, and management of fetal macrosomia in pregnancies complicated by diabetes mellitus. Sacks DA, Clin Obstet Gynecol 2007 50 980 989 10.1097/GRF.0b013e31815a6242 17982341
15. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Boney CM, Verma A, Tucker R, Vohr BR, Pediatrics 2005 115 290 296 10.1542/peds.2004-1808 15741354
16. Hyperglycemia and adverse pregnancy outcome (HAPO) study: associations with neonatal anthropometrics. Group HSCR, Diabetes 2009 58 453 459 19011170
17. Prevalence and covariates of obesity in Lebanon: findings from the first epidemiological study. Sibai AM, Hwalla N, Adra N, Rahal B, Obes Res 2003 11 1353 1361 10.1038/oby.2003.183 14627756
18. Detecting undiagnosed type 2 diabetes: family history as a risk factor and screening tool. Valdez R, J Diabetes Sci Technol 2009 3 722 726 10.1177/193229680900300417 20144319
19. Management of dyslipidemia in adults with diabetes. Haffner SM, Diabetes Care 2003 26 Suppl 1 83 86 12502625
20. Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state. Haffner SM, Mykkanen L, Festa A, Burke JP, Stern MP, Circulation 2000 101 975 980 10.1161/01.CIR.101.9.975 10704163
21. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK, JAMA 1990 263 2893 2898 10.1001/jama.1990.03440210043030 2338751
22. Lipids and lipoproteins in patients with type 2 diabetes. Krauss RM, Diabetes Care 2004 27 1496 1504 10.2337/diacare.27.6.1496 15161808
23. Diabetic neuropathies: a statement by the American diabetes association. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D, Diabetes Care 2005 28 956 962 10.2337/diacare.28.4.956 15793206
24. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Dyck PJ, Davies JL, Wilson DM, Service FJ, Melton LJ 3rd, O'Brien PC, Diabetes Care 1999 22 1479 1486 10.2337/diacare.22.9.1479 10480512
25. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H, Diabetologia 2001 44 Suppl 2 14 21 11587045
26. Prevalence of diabetes in greater Beirut. Hirbli KI, Jambeine MA, Slim HB, Barakat WM, Habis RJ, Francis ZM, Diabetes Care 2005 28 1262
27. National Diabetes Fact Sheet, Total prevalence of diabetes in the United States 2004 http://wwwcdcgov/diabetes/pubs/factsheethtm
28. Increasing prevalence of diagnosed diabetes - United States and Puerto Rico, 1995-2010. Centers for Disease Control and Prevention (CDC), MMWR Morb Mortal Wkly Rep 2012 61 918 921 23151951